Last quarter (Q3 2024), Vir Biotechnology's total revenue was $2.38M, a decrease of -37.32% from the same quarter last year. In Q3, Vir Biotechnology's net income was $-213.72M. See Vir Biotechnology’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 17.70M	$ 39.49M	$ 1.58B	$ 1.09B	$ 67.25M	$ 8.09M
Cost of Revenue	$ 938.00K	$ 2.77M	$ 146.32M	$ 65.86M	$ ―	$ ―
Gross Profit	$ 16.76M	$ 36.73M	$ 1.43B	$ 1.02B	$ 67.25M	$ 8.09M
Operating Expense	$ 700.03M	$ 770.49M	$ 636.41M	$ 674.66M	$ 373.35M	$ 186.07M
Operating Income	$ -715.68M	$ -684.30M	$ 833.07M	$ 420.75M	$ -296.98M	$ -177.98M
Net Non Operating Interest Income Expense	$ -47.53M	$ -86.99M	$ -28.09M	$ ―	$ ―	$ 8.51M
Other Income Expense	$ 6.07M	$ -30.88M	$ -106.88M	$ -137.40M	$ -7.49M	$ -10.83M
Pretax Income	$ -640.81M	$ -628.19M	$ 754.28M	$ 549.80M	$ -298.61M	$ -174.53M
Tax Provision	$ -9.33M	$ -13.08M	$ 238.44M	$ 21.22M	$ 54.00K	$ 154.00K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -631.48M	$ -615.06M	$ 515.84M	$ 528.58M	$ -298.67M	$ -174.68M
Basic EPS	$ -4.66	$ -4.59	$ 3.89	$ 4.07	$ -2.51	$ -5.76
Diluted EPS	$ -4.66	$ -4.59	$ 3.83	$ 3.96	$ -2.51	$ -5.76
Basic Average Shares	$ 541.80M	$ 134.13M	$ 132.61M	$ 129.88M	$ 119.16M	$ 30.35M
Diluted Average Shares	$ 541.80M	$ 134.13M	$ 134.81M	$ 133.44M	$ ―	$ 30.35M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 700.97M	$ 773.25M	$ 747.40M	$ 740.53M	$ 373.35M	$ 186.07M
Net Income From Continuing And Discontinued Operation	$ -631.48M	$ -615.06M	$ 515.84M	$ 528.58M	$ -298.67M	$ -174.68M
Normalized Income	$ -287.32M	$ ―	$ ―	$ ―	$ ―	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -640.81M	$ -628.19M	$ 833.07M	$ 420.75M	$ -296.98M	$ -174.53M
EBITDA	$ -624.91M	$ -608.79M	$ 839.85M	$ 426.56M	$ -291.54M	$ -170.19M

Currency in USD

Vir Biotechnology Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing